Medtronic Shares Soar 2.09% on $1.2 Billion Digital Health Push Rank 174th in U.S. Volume

. 11, , ranking 174th among U.S. equities. The stock's performance followed a strategic update from the medical device maker, . The announcement emphasized partnerships with regional hospitals to integrate AI-driven diagnostic tools, .

Separately, the company confirmed a regulatory review of its spinal fusion implant systems in the EU, which it characterized as "routine" during a conference call with investors. While no immediate production halts were announced, the review has prompted short-term volatility in the sector. Medtronic's shares outperformed its direct competitors in the session, .

To run this back-test accurately we need to nail down a few practical details first: 1. Universe • Do you want to rank all U.S.-listed common stocks (NYSE + NASDAQ) each day, or a different universe? 2. Trade timing • Buy price: today’s close or tomorrow’s open? • Sell price: tomorrow’s close (holding one full trading day) or today’s close (intraday)? 3. Weighting & sizing • Equal-weight across the 500 names, or volume-weighted / market-cap-weighted? 4. Friction • Ignore transaction costs and slippage, or include a default estimate (e.g., 2 bp per side)? Once I have those four items I can generate the data-retrieval plan and launch the back-test.